Oxford Biomedica plc (OXBDF)
Manufactures viral vectors for gene therapy companies to deliver experimental treatments to patients.
$8.00+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+28.0%
The outlook
OXBDF is trading at 8 and sits below both its 50- and 200-day moving averages, suggesting downward momentum. The stock trades in the lower portion of its 52-week range. Analyst coverage appears thin, and the overall data tilt is bearish.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range38% of the way from its 52-week low to high
Market cap
$968.3M
52-wk high
$12.61
52-wk low
$5.17
50-day avg
$8.07
200-day avg
$8.73
Trailing P/E
—